Market Analysis and Insights: Global Hemofiltration Machines Market
Hemofiltration machines are primarily used in kidney dysfunction or acute renal failure. Hemofiltration is a renal replacement therapy used for removal of metabolic waste from the blood such as creatinine and urea when kidney isn't functioning well.
Due to the COVID-19 pandemic, the global Hemofiltration Machines market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Portable Hemofiltration Machines accounting for % of the Hemofiltration Machines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
Hemofiltration machines are mainly used in intensive care units. Renal failure is the common condition observed in critically ill patients and according to national kidney foundation Inc., number of cases of acute kidney failure are increasing in developing countries such as China and India owing to increasing elderly population. Despite of significant technological advances in the renal replacement therapy, there is a significant need of high volume hemofiltration machines, which creates significant room for the growth of global hemofiltration systems market.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
Segment by Type
Portable Hemofiltration Machines
Desktop Hemofiltration Machines
Segment by Application
Hospitals
Ambulatory Surgical Centers
Outpatient Dialysis Units
Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Hemofiltration Machines market back to the pre-covid levels.
Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Competitive Outlook
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Asahi Kasei Corporation
Baxter International
Infomed
Fresenius Medical Care
B. Braun Melsungen
Nikkiso
Nipro, Medica
NxStage Medical
Bellco